Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SPYG✓SelectedUSD · SPYGGSK vs SPYG performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs SPYG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.3%
SPYG return
+361.0%
Excess return
-263.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioSPYGExcessAlpha
1D-1.6%-2.3%+0.8%-0.8%
7D-4.7%-6.6%+1.9%-2.6%
30D-4.7%-10.7%+6.0%-1.3%
3M-8.8%-10.2%+1.4%-5.8%
6M-4.6%-6.8%+2.1%-3.1%
YTD+1.0%+1.8%-0.8%-0.7%
1Y+6.9%+4.9%+2.0%+4.0%
3Y+52.5%+76.9%-24.3%+18.6%
5Y+40.3%+54.8%-14.5%+14.4%
All+97.3%+361.0%-263.7%-7.5%

Cumulative growth

Daily Returns

Daily percentage return beside SPYG.

Daily Out/Under-Performance

Portfolio return minus SPYG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SPYG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded SPYG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling